Holen Sie sich die Stockscreener-App
119.52
1.05%
-1.27
Handel nachbörslich:
119.40
-0.12
-0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$120.79
Offen:
$120.85
24-Stunden-Volumen:
11.92M
Relative Volume:
1.23
Marktkapitalisierung:
$295.19B
Einnahmen:
$65.51B
Nettoeinkommen (Verlust:
$8.93B
KGV:
33.64
EPS:
3.5532
Netto-Cashflow:
$14.12B
1W Leistung:
+3.78%
1M Leistung:
+7.31%
6M Leistung:
+20.81%
1J Leistung:
+51.35%
1-Tages-Spanne:
$118.69
$122.60
1-Wochen-Bereich:
$114.50
$123.46
52-Wochen-Spanne:
$76.66
$125.14
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
119.52 | 298.33B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
1,149.15 | 1.01T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
232.16 | 560.33B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
223.07 | 401.47B | 62.82B | 3.60B | 19.98B | 2.0274 |
AZN
Astrazeneca Plc
|
181.55 | 288.38B | 60.48B | 10.40B | 8.05B | 3.3297 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-20 | Eingeleitet | Barclays | Overweight |
| 2026-02-13 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Lilly Just Announced 3 Infectious Disease Acquisitions in 1 Day. Is This the Beginning of Its Post-Obesity Growth Strategy? - The Motley Fool
ETFs Investing in Merck & Co., Inc. Stocks - TradingView
Merck & Co., Inc. stock (US58933Y1055): Key catalysts after latest oncology updates - AD HOC NEWS
Merck & Co., Inc. stock (US58933Y1055): shares hover near recent highs as investors eye oncology pip - AD HOC NEWS
Merck & Co., Inc. $MRK Stake Cut by ING Groep NV - MarketBeat
Los Angeles Capital Management LLC Increases Stake in Merck & Co., Inc. $MRK - MarketBeat
Is Merck & Co. stock outperforming the S&P 500? - MSN
Dearborn Partners LLC Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Vestcor Inc Sells 22,707 Shares of Merck & Co., Inc. $MRK - MarketBeat
Westfield Capital Management Co. LP Invests $5.64 Million in Merck & Co., Inc. $MRK - MarketBeat
PBU The Pension Fund of Early Childhood & Youth Educators Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Sells 127,100 Shares of Merck & Co., Inc. $MRK - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Rating Increased to Buy at Wall Street Zen - MarketBeat
Is Merck & Co. (MRK) One of the Best Cheap Stocks to Buy for Beginners? - Insider Monkey
Merck & Co.: Why The Market Is Right To Start Buying Into Post-Keytruda Promise (NYSE:MRK) - Seeking Alpha
Merck & Co Inc (MRK) Stock Price, Trades & News - GuruFocus
Vise Technologies Inc. Has $11.65 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Prudential PLC Cuts Stake in Merck & Co., Inc. $MRK - MarketBeat
J.W. Cole Advisors Inc. Sells 16,943 Shares of Merck & Co., Inc. $MRK - MarketBeat
Daiwa Securities Group Inc. Sells 72,786 Shares of Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Quote Price and Forecast - CNN
Merck & Co., Inc. $MRK Shares Acquired by Arrowpoint Investment Partners Singapore Pte. Ltd. - MarketBeat
Top Merck & Co., Inc. (MRK) Competitors 2026 - MarketBeat
A Look at Merck & Co Inc (MRK) After 4.8% Gain -- GF Value $118. - GuruFocus
A Look at Merck & Co Inc (MRK) After 4.8% Gain -- GF Value $118.24 vs Price $120.26 - GuruFocus
Merck & Co Inc Stock (MRK) Moved Up by 3.33% on Jun 4: What Signal Does It Send? - TradingKey
TD Asset Management Inc Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Cibc World Market Inc. Purchases 320,143 Shares of Merck & Co., Inc. $MRK - MarketBeat
Westpac Banking Corp Sells 63,983 Shares of Merck & Co., Inc. $MRK - MarketBeat
Marble Wealth LLC Invests $1.13 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
CIBC Asset Management Inc Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Bank of New York Mellon Corp Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) Presents at American Society of Clinical Oncology (ASCO) Annual Meeting 2026Slideshow - Seeking Alpha
Merck & Co. Inc. stock (US58933Y1055): Shares ease as investors eye upcoming healthcare conference a - AD HOC NEWS
Merck & Co. (MRK) Announces Quarterly Dividend - Yahoo Finance
Is Merck & Co., Inc. (MRK) Expanding KEYTRUDA’s Reach With New EU Approval Momentum? - Insider Monkey
Natixis Advisors LLC Buys 217,330 Shares of Merck & Co., Inc. $MRK - MarketBeat
Pincus Capital Management LP Acquires Shares of 42,804 Merck & Co., Inc. $MRK - MarketBeat
Merck to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - BioSpace
Merck & Co., Inc. $MRK Shares Bought by One Capital Management LLC - MarketBeat
BNP Paribas Sells 17,542 Shares of Merck & Co., Inc. $MRK - MarketBeat
What Keeps Merck At The Center Of Global Healthcare Innovation? - Kalkine Media
Merck & Co., Inc. stock (US58933Y1055): shares steady on NYSE as investors digest recent news flow - AD HOC NEWS
Merck exec says company is discussing use of COVID antiviral drug in Ebola response - Reuters
Jim Cramer Notes “Merck’s Cancer Dominance Has Been Challenged of Late By JNJ” - Yahoo Finance
Merck & Co Inc Stock (MRK) Moved Down by 3.19% on Jun 1: A Full Analysis - TradingKey
Merck (MRK) Strengthens Capital Structure With Notes Offering - Yahoo Finance
Merck & Co. Inc. stock (US58933Y1055): Q3 2026 dividend confirmed as NYSE trading holds steady - AD HOC NEWS
Hillsdale Investment Management Inc. Trims Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):